Ten Chinese government departments, including the Ministry of Industry and Information Technology and the National Development and Reform Commission, jointly released the "15th Five-Year Plan for the Development of the Pharmaceutical Industry." The plan mandates accelerating the integration of artificial intelligence, quantum computing, supercomputing, and computational medicine to empower drug research and development through interdisciplinary collaboration among enterprises, universities, and medical institutions.
The initiative explores novel production models such as beyond-limit manufacturing, space pharmaceuticals, and biomanufacturing. It also targets breakthroughs in frontier technologies including gene editing, precise molecular delivery, cell programming, next-generation brain-computer interfaces, and xenotransplanted organs to cultivate new industry growth points.
China Unveils 15th Five-Year Pharma Plan Integrating AI and Quantum Computing for Drug R&D
Disclaimer: The content provided on Phemex News is for informational purposes only. We do not guarantee the quality, accuracy, or completeness of the information sourced from third-party articles. The content on this page does not constitute financial or investment advice. We strongly encourage you to conduct you own research and consult with a qualified financial advisor before making any investment decisions.
